GSK 2023 ApS: Financial statements 2014
CVR: 43456415
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
GSK 2023 ApS (CVR 43456415) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 2,857,630 and a net result of DKK 5,673,521 compared with DKK 3,833,953 the year before. That is a decrease of 0.6% compared with the year before. Equity in the 2014 report amounted to DKK 47,244,561. The solvency ratio was 77.1%.
- Gross Profit
- DKK 2,857,630
- Profit/Loss
- DKK 5,673,521
- Equity
- DKK 47,244,561
- Total Assets
- DKK 61,258,331
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 2.9 mio. | 5.7 mio. | 47.2 mio. | - |
| 2013 | - | 2.9 mio. | 3.8 mio. | 44.8 mio. | - |
| 2012 | - | 3.1 mio. | 3.9 mio. | 40.8 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
GSK 2023 ApS has published its annual report for 2013. Gross profit came to DKK 2,876,263, and the net result was DKK 3,833,953.
About GSK 2023 ApS
GSK 2023 ApS is a Danish company of the type Anpartsselskab based in Sæby, founded in 1972. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named B6 HOLDING A/S and B 6 AF 1972 A/S. The management consists of Brian Stenbro. The board consists of Kurt Valdemar Stenbro (chair), Brian Stenbro and Malene Stenbro. The company is owned by M.A.S.T. Holding ApS, BriSt Holding 2023 ApS and KVS Holding, Sæby ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -30,332 and a net result of DKK -5,937 compared with DKK 372,677 the year before. Equity in the 2025 report amounted to DKK 4,181,703.